Dual targeting of IGF-1R and ErbB3 as a potential therapeutic regimen for ovarian cancer

Therapeutically targeting receptor tyrosine kinases has proven to be paramount to overcoming chemotherapy resistance in several cancer indications, improving patient outcomes. Insulin-Like Growth Factor Receptor 1 (IGF-1R) and Epidermal Growth Factor Receptor 3 (ErbB3) have been implicated as two su...

Descripción completa

Detalles Bibliográficos
Autores principales: Camblin, Adam J., Tan, Gege, Curley, Michael D., Yannatos, Isabel, Iadevaia, Sergio, Rimkunas, Victoria, Mino-Kenudson, Mari, Bloom, Troy, Schoeberl, Birgit, Drummond, Daryl C., Lugovskoy, Alexey A., Louis, Chrystal U., Askoxylakis, Vasileios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856132/
https://www.ncbi.nlm.nih.gov/pubmed/31728045
http://dx.doi.org/10.1038/s41598-019-53322-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856132/
https://www.ncbi.nlm.nih.gov/pubmed/31728045
http://dx.doi.org/10.1038/s41598-019-53322-y

Ejemplares similares